Details for Patent: 12,144,890
Which drugs does patent 12,144,890 protect, and when does it expire?
Patent 12,144,890 protects EXPAREL and is included in one NDA.
This patent has thirteen patent family members in seven countries.
Summary for Patent: 12,144,890
| Title: | Manufacturing of bupivacaine multivesicular liposomes |
| Abstract: | Embodiments of the present application relate to batches of bupivacaine multivesicular liposomes (MVLs) prepared by a commercial manufacturing process using independently operating dual tangential flow filtration modules. |
| Inventor(s): | Jeffrey S. Hall, David J. Turnbull, John J. Grigsby, Jr., Soroush M. Ardekani, Kathleen D. A. Los |
| Assignee: | Pacira Pharmaceuticals Inc |
| Application Number: | US18/325,927 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 12,144,890 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Process; Dosage form; |
Drugs Protected by US Patent 12,144,890
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pacira Pharms Inc | EXPAREL | bupivacaine | INJECTABLE, LIPOSOMAL;INJECTION | 022496-001 | Oct 28, 2011 | RX | Yes | Yes | 12,144,890 | ⤷ Start Trial | Y | METHOD OF PROVIDING LOCAL OR REGIONAL ANALGESIA, FOR EXAMPLE, VIA INFILTRATION TO PROVIDE POSTSURGICAL LOCAL ANALGESIA OR VIA INTERSCALENE BRACHIAL PLEXUS NERVE BLOCK TO PROVIDE POSTSURGICAL REGIONAL ANALGESIA | ⤷ Start Trial | |||
| Pacira Pharms Inc | EXPAREL | bupivacaine | INJECTABLE, LIPOSOMAL;INJECTION | 022496-002 | Oct 28, 2011 | RX | Yes | Yes | 12,144,890 | ⤷ Start Trial | Y | METHOD OF PROVIDING LOCAL OR REGIONAL ANALGESIA, FOR EXAMPLE, VIA INFILTRATION TO PROVIDE POSTSURGICAL LOCAL ANALGESIA OR VIA INTERSCALENE BRACHIAL PLEXUS NERVE BLOCK TO PROVIDE POSTSURGICAL REGIONAL ANALGESIA | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,144,890
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| China | 114209654 | ⤷ Start Trial | |||
| Denmark | 4032528 | ⤷ Start Trial | |||
| European Patent Office | 4032528 | ⤷ Start Trial | |||
| European Patent Office | 4740937 | ⤷ Start Trial | |||
| Spain | 3073947 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
